Results For "NABL"

2021 News Found

interviews | February 09, 2022

We expect to turn profitable in two years: M Satyendra (Satish), Managing Director, Athena Global Technologies & MedleyMed

MedleyMed is present across the pharma and healthcare value chain. It offers digital solutions to all stake holders and is in the process of expanding its operations in India and USA. In an interview with Thomas C Thottathil, M Satyendra (Satish), Managing Director, Athena Global Technologies & MedleyMed discussed his plans and opportunities in India

Biotech | February 09, 2022

EdiGene and Neukio collaborate to develop next-generation immune cell therapies

The collaboration will leverage EdiGene’s expertise in high-throughput genome editing screening and Neukio’s strength in the development and manufacturing of induced pluripotent stem cell (iPSC) and natural killer cell (NK Cell)

People | February 09, 2022

Strand Therapeutics appoints Dr. Prashant Nambiar as Senior VP

Senior R&D leader from Pfizer and bluebird bio to support Strand’s platform of programmable mRNA-based therapeutics

Biotech | February 09, 2022

C2i Genomics Partners with Twist Bioscience for cancer detection

Twist will leverage C2i’s leadership in whole-genome cancer signatures across solid cancers to generate unique synthetic reference materials for cancer detection validation in labs across the globe

Medical Device | February 08, 2022

Thermo Fisher Scientific launches rapid environmental PCR testing solution

Rapid testing produces air sample results in 30 minutes

News | February 08, 2022

Merck KGaA restructures life science business to support long-term growth

Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services

News | February 08, 2022

AsterDM Healthcare Q3FY22 PAT at Rs 148.34 cr.

Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021

News | February 08, 2022

Origin Materials and Minafin form strategic partnership for biobased chemicals

The partnership includes multiple collaboration areas and is an important milestone for bringing cost-competitive biobased products to the market, with applications in the pharmaceutical, agricultural, cosmetics and personal care, and automotive industries

News | February 08, 2022

Biosynthetic Technologies raises $7.5 million

Biosynthetic Technologies produces estolides, a new class of biobased synthetic oils used in a number of applications, including motor oil, industrial lubricants, pharmaceuticals, and personal care.

Biotech | February 07, 2022

Lay Sciences launch ImmynlgY, an oral antibody to neutralize Covid-19

ImmunIgY, has been developed by ReaGene Biosciences, Kyntox Bio and ProdigY, and is an antibody-containing beverage that can potentially prevent viral entry, regardless of vaccination or infection status